Kazuto Yoshimi

5PUBLICATIONS
19CO-AUTHORS
Neurology and neuromuscular diseasesPowder and particle technologyCell and nuclear divisionInstrumental methods (excl. immunological and bioassay methods)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 25, 2026
Interplay between DYRK1A dosage and aneuploidy-induced neuropathology in Down syndrome.

Toshihiko Nambara, Joo Yeon Lee, Masaki Minami

|Jan 06, 2026
CRISPR-Cas3-based editing for targeted deletions in a mouse model of transthyretin amyloidosis.

Saeko Ishida, Yusuke Sato, Keisuke Chosa

|Nov 20, 2024
CRISPR Diagnostics for Quantification and Rapid Diagnosis of Myotonic Dystrophy Type 1 Repeat Expansion Disorders.

Koji Asano, Kazuto Yoshimi, Kohei Takeshita

|Aug 30, 2022
Dynamic mechanisms of CRISPR interference by Escherichia coli CRISPR-Cas3.

Kazuto Yoshimi, Kohei Takeshita, Noriyuki Kodera

|Mar 15, 2021
Chemokine ligand 28 (CCL28) negatively regulates trabecular bone mass by suppressing osteoblast and osteoclast activities.

Rina Iwamoto, Takumi Takahashi, Kazuto Yoshimi

Pageof 1